Frontiers | FcγR Binding and ADCC Activity of Human IgG Allotypes
AP Anti-Mouse Kappa, 187.1 | SouthernBiotech
LIGELIZUMAB N14 Page 1 of 2 120 October 29, 2014 STATEMENT ON A NONPROPRIETARY NAME ADOPTED BY THE USAN COUNCIL USAN (CD-23) LIG
Multimerization is required for antigen binding activity of an engineered IgM/IgG chimeric antibody recognizing a skin-related antigen | Scientific Reports
Rat IgG1 Kappa Light Chain Isotype Control (KLH/G1-2-2) (NBP1-51817): Novus Biologicals
PDF) Best Practice for the Administration of Daratumumab in Multiple Myeloma: Australian Myeloma Nurse Expert Opinion
Frontiers | Mechanisms of Action of the New Antibodies in Use in Multiple Myeloma
Immunoglobulin germline gene variation and its impact on human disease | Genes & Immunity
Frontiers | Immunoglobulin Expression in Cancer Cells and Its Critical Roles in Tumorigenesis